India’s pharmaceutical sector considers trade deals as a pathway to innovation amid tariff threats

As the US threatens new import barriers, Indian drugmakers explore the potential of free trade agreements to enhance market access, but emphasise the need for regulatory strength and innovation to remain competitive. Donald Trump’s latest tariff warning has once again…













